发明名称 |
Bicyclic heterocyclic spiro compounds |
摘要 |
There are provided certain bicyclic heterocyclic compounds that act as M1 muscarinic receptor modulators. Compositions containing these compounds and their use are also disclosed. |
申请公布号 |
US9034891(B2) |
申请公布日期 |
2015.05.19 |
申请号 |
US201313804725 |
申请日期 |
2013.03.14 |
申请人 |
ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH |
发明人 |
Fisher Abraham;Bar-Ner Nira;Nachum Victoria |
分类号 |
C07D513/10;C07D498/10;C07D491/10;C07D491/20;C07D495/10 |
主分类号 |
C07D513/10 |
代理机构 |
Fourth Dimension IP |
代理人 |
Fourth Dimension IP ;Feigelson Daniel |
主权项 |
1. A method of treating a disease or condition selected from the group consisting of Alzheimer's disease, Insulin resistance syndrome, type-2 diabetes, Parkinson's Disease, Lewy Body Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Lobar Degeneration, comprising administering the compound of the structureor a pharmaceutically acceptable salt thereof, to a patient having such a disease or condition. |
地址 |
Ness Ziona IL |